211 filings
Page 5 of 11
DEFA14A
jwxb0
27 Apr 21
Additional proxy soliciting materials
5:19pm
8-K
mrtv5
9 Apr 21
Entry into a Material Definitive Agreement
4:19pm
8-K
uns5q11
11 Mar 21
Mersana Therapeutics Announces Appointment of Allene Diaz to Board of Directors
9:17am
8-K
rrsaphu9gg
26 Feb 21
Mersana Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
6:29am
8-K
1nvpavvodswpw
5 Jan 21
Mersana Therapeutics Announces Corporate and Pipeline Updates and 2021 Goals and Anticipated Milestones
9:58am
8-K
juff k7w7czlfh
30 Nov 20
Mersana Therapeutics Appoints Arvin Yang, M.D., Ph.D. as Senior Vice President
8:15am
8-K
4suqr0l d38swd4eta
9 Nov 20
Mersana Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update
6:30am
8-K
nd80f9m 0is5gfcpb
17 Sep 20
Mersana Therapeutics Reports Updated Interim Data from the Ovarian Cancer Cohort of the XMT-1536 Phase 1 Expansion Study
6:30am
8-K
y7semo7
3 Sep 20
Entry into a Material Definitive Agreement
6:36am
8-K
ska xxpe1kf1kt
7 Aug 20
Mersana Therapeutics Announces Second Quarter 2020 Financial Results and Provides Business Update
6:30am
8-K
k6g562bnhabm078oz8l
16 Jun 20
Submission of Matters to a Vote of Security Holders
5:20pm
8-K
mpo pgfa8ll4hh8
1 Jun 20
Entry into a Material Definitive Agreement
5:22pm
424B5
ywg0l 6wj90g3a5sh46
29 May 20
Prospectus supplement for primary offering
4:14pm
S-3MEF
7ujfg0nauz
28 May 20
Registration of additional securities for an S-3
9:41pm
424B5
t8d6krprktl zcp
28 May 20
Prospectus supplement for primary offering
6:08am